Skip to content

Body Clocks - Coordination of Peripheral and Central Oscillators

Confluence of Sleep, Circadian Rhythms, and the Menstrual Cycle on Injury Risk in Women

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07459764
Enrollment
20
Registered
2026-03-10
Start date
2026-04-15
Completion date
2026-11-30
Last updated
2026-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Circadian Dysregulation

Keywords

sleep, circadian, menstrual, women's health

Brief summary

The investigators are conducting an observational trial examining young women over the course of 28 days in which we are monitoring movement, sleep, heart rate, oxygen saturation, gut physiology, light, and menstrual cycle. The inter- and independence of the cyclicity of these variables with each other, the circadian cycle, the menstrual cycle, and the sleep cycle will be tested.

Detailed description

For 28 days, women will wear devices to capture: ambient light exposure, lower limb biomechanics, sleep, oxygen saturation, heart rate, temperature, and gut physiology. Twice during the study, women will have saliva collected for 7 hours under dim light conditions in order to determine melatonin concentrations. During this 7-hour period, two blood draws for determination of proteomic profiles will also occur. Daily urine samples will be tested for LH until the presence of the LH surge to help identify menstrual phase.

Interventions

None listed

Sponsors

Stanford University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* Regular menstrual cycle (21-35 days) * 18-30 years old

Exclusion criteria

* Neuromuscular or neurodegenerative disease * Gut disorders * circadian sleep disorders * prescription medications affecting sleep * recovering from physical injury * taking hormonal birth control

Design outcomes

Primary

MeasureTime frameDescription
Stride time28 daysDuration of each stride

Secondary

MeasureTime frameDescription
Sleep28 daysDaily sleep duration determined through actigraphy

Countries

United States

Contacts

CONTACTLara Weed, BS, MS
weed@stanford.edu650-723-2300
PRINCIPAL_INVESTIGATORJamie M Zeitzer, PhD

Stanford University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 13, 2026